This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tremblay, F. Articles by Gimeno, R. E. Search for Related Content PubMed PubMed Citation Articles by Tremblay, F. Articles by Gimeno, R. E.

Normal Food Intake and Body Weight in Mice Lacking the G Protein-Coupled Receptor GPR39

Cardiovascular and Metabolic Diseases (F.T., M.P., L.D.K., J.F.T., R.E.G.) and Women’s Health and Musculoskeletal Biology (E.S.), Wyeth Research, Cambridge, Massachusetts 02140

Address all correspondence and requests for reprints to: Dr. Ruth E. Gimeno, Cardiovascular and Metabolic Diseases, Wyeth Research, 200 Cambridge Park Drive (T4007E), Cambridge, Massachusetts 02140. E-mail: rgimeno{at}wyeth.com.

It has been recently proposed that obestatin, a peptide encoded by the ghrelin gene, reduces food intake by activating the orphan G protein-coupled receptor GPR39. To gain further insights into the role of GPR39 in body weight homeostasis, we characterized the phenotype of mice with targeted disruption of the GPR39 gene. Body weight, adiposity, and food intake were found to be similar between GPR39^+/+ and GPR39^–/– mice. Furthermore, fasting glucose and insulin levels were similar between both genotypes. Injection of obestatin peptide (1 µmol/kg, ip) obtained from multiple sources did not consistently inhibit food intake in wild-type mice after an overnight fast, and no difference in food intake was observed between wild-type and GPR39 knockout mice after injection of the peptide. Finally, ectopic expression of GPR39 in HEK293T cells revealed a constitutive activation of the receptor that was unaffected by stimulation with obestatin. Our phenotypic characterization suggests that GPR39 is not a major modulator of food intake in mice, although a more subtle role cannot be excluded. The role of GPR39 in normal physiology requires further study and should be conducted independently of the function of obestatin.

This article has been cited by other articles:

				C. J P Alvarez, M. Lodeiro, M. Theodoropoulou, J. P Camina, F. F Casanueva, and Y. Pazos Obestatin stimulates Akt signalling in gastric cancer cells through {beta}-arrestin-mediated epidermal growth factor receptor transactivation Endocr. Relat. Cancer, June 1, 2009; 16(2): 599 - 611. [Abstract] [Full Text] [PDF]

				B. Holst, K. L. Egerod, C. Jin, P. S. Petersen, M. V. Ostergaard, J. Hald, A. M. E. Sprinkel, J. Storling, T. Mandrup-Poulsen, J. J. Holst, et al. G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction Endocrinology, June 1, 2009; 150(6): 2577 - 2585. [Abstract] [Full Text] [PDF]

				F. Tremblay, A.-M. T. Richard, S. Will, J. Syed, N. Stedman, M. Perreault, and R. E. Gimeno Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo Endocrinology, June 1, 2009; 150(6): 2586 - 2595. [Abstract] [Full Text] [PDF]

				X. Li, J. He, W. Hu, and Z. Yin The Essential Role of Endogenous Ghrelin in Growth Hormone Expression during Zebrafish Adenohypophysis Development Endocrinology, June 1, 2009; 150(6): 2767 - 2774. [Abstract] [Full Text] [PDF]

				K. Ataka, A. Inui, A. Asakawa, I. Kato, and M. Fujimiya Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1210 - G1218. [Abstract] [Full Text] [PDF]

				R. Granata, F. Settanni, D. Gallo, L. Trovato, L. Biancone, V. Cantaluppi, R. Nano, M. Annunziata, P. Campiglia, E. Arnoletti, et al. Obestatin Promotes Survival of Pancreatic {beta}-Cells and Human Islets and Induces Expression of Genes Involved in the Regulation of {beta}-Cell Mass and Function Diabetes, April 1, 2008; 57(4): 967 - 979. [Abstract] [Full Text] [PDF]

				W. K Samson, G. L C Yosten, J.-K. Chang, A. V Ferguson, and M. M White Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis J. Endocrinol., March 1, 2008; 196(3): 559 - 564. [Abstract] [Full Text] [PDF]

				I. Yamamoto, Y. Sakaguchi, M. Numao, A. Tsukada, N. Tsushima, and M. Tanaka Primary Structure and Tissue Distribution of GPR39 Messenger Ribonucleic Acid in Japanese Quail, Coturnix japonica Poult. Sci., November 1, 2007; 86(11): 2472 - 2476. [Abstract] [Full Text] [PDF]

				A. Garg The Ongoing Saga of Obestatin: Is It a Hormone? J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3396 - 3398. [Full Text] [PDF]

				K. L. Egerod, B. Holst, P. S. Petersen, J. B. Hansen, J. Mulder, T. Hokfelt, and T. W. Schwartz GPR39 Splice Variants Versus Antisense Gene LYPD1: Expression and Regulation in Gastrointestinal Tract, Endocrine Pancreas, Liver, and White Adipose Tissue Mol. Endocrinol., July 1, 2007; 21(7): 1685 - 1698. [Abstract] [Full Text] [PDF]

				M. P. Richards and M. Proszkowiec-Weglarz Mechanisms Regulating Feed Intake, Energy Expenditure, and Body Weight in Poultry Poult. Sci., July 1, 2007; 86(7): 1478 - 1490. [Abstract] [Full Text] [PDF]

				P. Zizzari, R. Longchamps, J. Epelbaum, and M. T. Bluet-Pajot Obestatin Partially Affects Ghrelin Stimulation of Food Intake and Growth Hormone Secretion in Rodents Endocrinology, April 1, 2007; 148(4): 1648 - 1653. [Abstract] [Full Text] [PDF]